Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Obesity | Research article

Risk factors of recurrent erysipelas in adult Chinese patients: a prospective cohort study

Authors: Ang Li, Ni Wang, Lingzhi Ge, Hongyan Xin, Wenfei Li

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Erysipelas is a common skin infection that is prone to recur. Recurrent erysipelas has a severe effect on the quality of life of patients. The present study aimed to investigate the risk factors of recurrent erysipelas in adult Chinese patients.

Methods

A total of 428 Chinese patients with erysipelas who met the inclusion criteria were studied. The patients were divided into the nonrecurrent erysipelas group and the recurrent erysipelas group. Clinical data were collected on the first episode and relapse of erysipelas. The patients were followed up every 3 months. Statistical analysis was performed to analyze and determine the risk factors of erysipelas relapse.

Results

Univariate analysis was performed to analyze the data, including surgery, types of antibiotics administered in the first episode, obesity, diabetes mellitus, venous insufficiency, lymphedema, and malignancy. The differences between the groups were statistically significant (p < 0.05). The Cox proportional hazards regression model analysis showed that the final risk factors included surgery, obesity, diabetes mellitus, venous insufficiency, and lymphedema.

Conclusions

Surgery, obesity, diabetes mellitus, venous insufficiency, and lymphedema are considered as risk factors for recurrent erysipelas.
Literature
1.
go back to reference Brishkoska-Boshkovski V, Kondova-Topuzovska I, Damevska K, Petrov A. Comorbidities as risk factors for acute and recurrent erysipelas. Open Access Maced J Med Sci. 2019;7:937–42.CrossRef Brishkoska-Boshkovski V, Kondova-Topuzovska I, Damevska K, Petrov A. Comorbidities as risk factors for acute and recurrent erysipelas. Open Access Maced J Med Sci. 2019;7:937–42.CrossRef
2.
go back to reference Sunderkötter C, Becker K, Eckmann C, Graninger W, Kujath P, Schöfer H. S2k guidelines for skin and soft tissue infections excerpts from the S2k guidelines for “calculated initial parenteral treatment of bacterial infections in adults - update 2018”. J Dtsch Dermatol Ges. 2019;17:345–69.PubMed Sunderkötter C, Becker K, Eckmann C, Graninger W, Kujath P, Schöfer H. S2k guidelines for skin and soft tissue infections excerpts from the S2k guidelines for “calculated initial parenteral treatment of bacterial infections in adults - update 2018”. J Dtsch Dermatol Ges. 2019;17:345–69.PubMed
3.
go back to reference Sunderkötter C, Becker K, Eckmann C, Graninger W, Kujath P, Schöfer H. Calculated initial parenteral treatment of bacterial infections: Skin and soft tissue infections. GMS Infect Dis. 2020;8:Doc11 eCollection 2020.PubMedPubMedCentral Sunderkötter C, Becker K, Eckmann C, Graninger W, Kujath P, Schöfer H. Calculated initial parenteral treatment of bacterial infections: Skin and soft tissue infections. GMS Infect Dis. 2020;8:Doc11 eCollection 2020.PubMedPubMedCentral
4.
go back to reference Pavlotsky F, Amrani S, Trau H. Recurrent erysipelas: risk factors. J Dtsch Dermatol Ges. 2004;2:89–95.CrossRef Pavlotsky F, Amrani S, Trau H. Recurrent erysipelas: risk factors. J Dtsch Dermatol Ges. 2004;2:89–95.CrossRef
5.
go back to reference Jia W. Obesity in China: its characteristics, diagnostic criteria, and implications. Front Med. 2015;9:129–33.CrossRef Jia W. Obesity in China: its characteristics, diagnostic criteria, and implications. Front Med. 2015;9:129–33.CrossRef
6.
go back to reference McNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez J, Mirzoyev SA, Baddour LM. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007;167:709–15.CrossRef McNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez J, Mirzoyev SA, Baddour LM. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007;167:709–15.CrossRef
7.
go back to reference Jendoubi F, Rohde M, Prinz JC. Intracellular streptococcal uptake and persistence: a potential cause of erysipelas recurrence. Front Med. 2019;6:6.CrossRef Jendoubi F, Rohde M, Prinz JC. Intracellular streptococcal uptake and persistence: a potential cause of erysipelas recurrence. Front Med. 2019;6:6.CrossRef
8.
go back to reference Mokni M, Dupuy A, Denguezli M, Dhaoui R, Bouassida S, Amri M, Fenniche S, Zeglaoui F, Doss N, Nouira R, Ben Osman-Dhahri A, Zili J, Mokhtar I, Kamoun MR, Zahaf A, Chosidow O. Risk factors for erysipelas of the leg in Tunisia: a multicenter case-controlstudy. Dermatology. 2006;212:108–12.CrossRef Mokni M, Dupuy A, Denguezli M, Dhaoui R, Bouassida S, Amri M, Fenniche S, Zeglaoui F, Doss N, Nouira R, Ben Osman-Dhahri A, Zili J, Mokhtar I, Kamoun MR, Zahaf A, Chosidow O. Risk factors for erysipelas of the leg in Tunisia: a multicenter case-controlstudy. Dermatology. 2006;212:108–12.CrossRef
9.
go back to reference Wojas-Pelc A, Alekseenko A, Jaworek AK. Erysipelas--course of disease, recurrence, complications; a 10 years retrospective study. Przegl Epidemiol. 2007;61:457–64 Article in Polish.PubMed Wojas-Pelc A, Alekseenko A, Jaworek AK. Erysipelas--course of disease, recurrence, complications; a 10 years retrospective study. Przegl Epidemiol. 2007;61:457–64 Article in Polish.PubMed
10.
go back to reference Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas--risk factors and clinical presentation. BMC Infect Dis. 2014;14:270.CrossRef Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas--risk factors and clinical presentation. BMC Infect Dis. 2014;14:270.CrossRef
11.
go back to reference Ezawa M, Sasaki H, Yamada K, Takano H, Iwasaka T, Nakao Y, Yokochi T, Okamoto A. Long term outcomes from lymphatic venous anastomosis after total hysterectomy to prevent postoperative lymphedema in lower limb. BMC Surg. 2019;19:177.CrossRef Ezawa M, Sasaki H, Yamada K, Takano H, Iwasaka T, Nakao Y, Yokochi T, Okamoto A. Long term outcomes from lymphatic venous anastomosis after total hysterectomy to prevent postoperative lymphedema in lower limb. BMC Surg. 2019;19:177.CrossRef
13.
go back to reference Rob F, Hercogová J. Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients. J Dermatolog Treat. 2018;29:39–43.CrossRef Rob F, Hercogová J. Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients. J Dermatolog Treat. 2018;29:39–43.CrossRef
14.
go back to reference Zhu H, Han SY, Li XG, Zhou XG, Zhang QF. DNA damage in peripheral blood lymphocytes of ovarian cancer patients after radiotherapy. Eur J Gynaecol Oncol. 2013;34:450–2.PubMed Zhu H, Han SY, Li XG, Zhou XG, Zhang QF. DNA damage in peripheral blood lymphocytes of ovarian cancer patients after radiotherapy. Eur J Gynaecol Oncol. 2013;34:450–2.PubMed
15.
go back to reference Celenay ST, Ucurum SG, Kaya DO. Comparison of spinal alignment and mobility in women with and without post modified radical mastectomy unilateral lymphoedema. Clin Breast Cancer. 2019;20(19):30717 [Epub ahead of print]. Celenay ST, Ucurum SG, Kaya DO. Comparison of spinal alignment and mobility in women with and without post modified radical mastectomy unilateral lymphoedema. Clin Breast Cancer. 2019;20(19):30717 [Epub ahead of print].
16.
go back to reference Sundaresan S, Migden MR, Silapunt S. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol. 2017;18:383–90.CrossRef Sundaresan S, Migden MR, Silapunt S. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol. 2017;18:383–90.CrossRef
17.
go back to reference Brennecke S, Hartmann M, Schöfer H, Rasokat H, Tschachler E, Brockmeyer NH. Treatment of erysipelas in Germany and Austria--results of a survey in German and Austrian dermatological clinics. J Dtsch Dermatol Ges. 2005;3:263–70 Article in German.CrossRef Brennecke S, Hartmann M, Schöfer H, Rasokat H, Tschachler E, Brockmeyer NH. Treatment of erysipelas in Germany and Austria--results of a survey in German and Austrian dermatological clinics. J Dtsch Dermatol Ges. 2005;3:263–70 Article in German.CrossRef
18.
go back to reference Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, Jussila T, Syrjänen J. Factors predisposing to acute and recurrent bacterial nonnecrotizing cellulitisin hospitalized patients: a prospective case-control study. Clin Microbiol Infect. 2010;16:729–34.CrossRef Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, Jussila T, Syrjänen J. Factors predisposing to acute and recurrent bacterial nonnecrotizing cellulitisin hospitalized patients: a prospective case-control study. Clin Microbiol Infect. 2010;16:729–34.CrossRef
19.
go back to reference Lazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Inf Secur. 2005;51:383–9. Lazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Inf Secur. 2005;51:383–9.
20.
Metadata
Title
Risk factors of recurrent erysipelas in adult Chinese patients: a prospective cohort study
Authors
Ang Li
Ni Wang
Lingzhi Ge
Hongyan Xin
Wenfei Li
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05710-3

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue